Whether the role of glial cells in sAD is distinct from that in fAD has yet to be determined but evidence from the identification of AD risk genes enriched in glial cell types, e.g. APOE4 in astrocytes and microglia and TREM2 in microglia, suggests that this may be a key area for investigation. The gene discussed is APOE; the disease is Alzheimer disease.